Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: Uptake of diclofenac for a controlled release formulation.
about
Multifaceted role of clay minerals in pharmaceuticalsStructural characterization and thermal and chemical stability of bioactive molecule-hydrotalcite (LDH) nanocomposites.Influence of hydrothermal treatment on physicochemical properties and drug release of anti-inflammatory drugs of intercalated layered double hydroxide nanoparticles.Sustained release of prindopril erbumine from its chitosan-coated magnetic nanoparticles for biomedical applications.The application of layered double hydroxide clay (LDH)-poly(lactide-co-glycolic acid) (PLGA) film composites for the controlled release of antibiotics.Montmorillonite-Alginate Composites as a Drug delivery System: Intercalation and In vitro Release of Diclofenac sodium.Anticancer nanodelivery system with controlled release property based on protocatechuate-zinc layered hydroxide nanohybrid.Preparation and characterization of 6-mercaptopurine-coated magnetite nanoparticles as a drug delivery systemSynthesis, characterization, and antimicrobial activity of an ampicillin-conjugated magnetic nanoantibiotic for medical applications.Comparative study of Mg/Al- and Zn/Al-layered double hydroxide-perindopril erbumine nanocomposites for inhibition of angiotensin-converting enzyme.In vitro inhibition of histamine release behavior of cetirizine intercalated into Zn/Al- and Mg/Al-layered double hydroxides.Controlled release and angiotensin-converting enzyme inhibition properties of an antihypertensive drug based on a perindopril erbumine-layered double hydroxide nanocomposite.Mucoadhesive bilayered tablets for buccal sustained release of flurbiprofen.Layered Double Hydroxide-Based Functional Nanohybrids as Controlled Release Carriers of Pharmaceutically Active Ingredients.Anticancer activity of ferulic acid-inorganic nanohybrids synthesized via two different hybridization routes, reconstruction and exfoliation-reassembly.Controlled release of organic-inorganic nanohybrid:cefadroxil intercalated Zn-Al-layered double hydroxide.Preparation of pH-Sensitive Polymers/Layered Double Hydroxide Hybrid Beads for Controlled Release of InsulinControlled Release Kinetics in Hydroxy Double Salts: Effect of Host Anion Structure
P2860
Q28817909-463F8B7E-3E0F-48C9-8F84-42F00A3096AFQ30656468-A5A7D397-088A-42B7-B42E-3B8B50B7572BQ33858666-BE729844-6213-4F6F-A1A7-4082CDD7897DQ37420871-E2E27E20-C574-42DF-8107-33BDA1CAB764Q38325896-C32A5493-D9A9-4BB5-B828-B7B5882FAC58Q38549275-BE207029-5BE8-4856-80DC-B84BC1B6C739Q38971823-5CC01904-748B-46C2-8E86-F629C8E0B49EQ39084200-5B824CE0-D4CA-4F59-826C-74556A01CEDCQ39089851-C92D5786-96C3-4B69-88FD-B4E916F90D6AQ39294864-3D9BCEFE-3C18-46EF-A42B-80A88D73B577Q39320851-CF7F7DF0-B4A5-455A-B161-9DAECE12E003Q39343784-AC9E5644-4519-4BE1-B8DD-4EDCE0E268A2Q47101536-FE8B4BD8-772D-4837-9F81-EDDACAB0A238Q50117704-8F8B3100-B834-48E0-8771-4226677DBCE8Q53634599-08B93475-E3CD-4AD0-BC7D-D45DEA5F6240Q55206230-2CA38768-6C11-4934-8716-B68B86583B33Q57369146-26239149-56FB-4F7E-BD0F-A9B264D4C28EQ59048136-6F92E5B3-61A7-462A-85CD-C96F7EB6FE3A
P2860
Intercalation compounds of hydrotalcite-like anionic clays with anti-inflammatory agents, II: Uptake of diclofenac for a controlled release formulation.
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
Intercalation compounds of hyd ...... ontrolled release formulation.
@en
type
label
Intercalation compounds of hyd ...... ontrolled release formulation.
@en
prefLabel
Intercalation compounds of hyd ...... ontrolled release formulation.
@en
P2093
P2860
P356
P1433
P1476
Intercalation compounds of hyd ...... ontrolled release formulation.
@en
P2093
Giuliano Grandolini
Giuseppe Fardella
Luana Perioli
Maria Cristina Tiralti
Valeria Ambrogi
P2860
P2888
P356
10.1208/PT030326
P407
P577
2002-01-01T00:00:00Z
P5875
P6179
1064225341